Home / Resource Library / Long term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse

Long term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse

Results of a study examining chemoimmunotherapy for first line treatment of Burkitt’s lymphoma.